Left atrial voltage characteristics in patients with persistent atrial fibrillation

Aim. The aim of the study was to assess the impact of comorbidities and duration of arrhythmic anamnesis on the results of left atrium voltage mapping in patients with persistent atrial fibrillation (AF).
Methods. The study enrolled 50 patients who underwent the first radiofrequency ablation of persistent AF. Left atrium endocardial voltage maps were obtained using a 3D electroanatomical mapping system during AF. The voltage maps consisted of at least 2,000 points, with an average of 2,128±104 points. Low-voltage areas (LVA) were defined as <0.5 mV. The percentage of LVA% and very LVA% were calculated. Results. We found a statistically significant correlation of LVA% with age (p<0.001, r=0.720), female sex (p=0.016), and the duration of arrhythmic history at the time of the start of persistence (p<0.001, r=0.503). Based on the data obtained, an original scale was developed to predict LVA%. The scale includes age, female sex, and the duration of arrhythAim. The aim of the study was to assess the impact of comorbidities and duration of arrhythmic anamnesis on the results of left atrium voltage mapping in patients with persistent atrial fibrillation (AF).
Methods. The study enrolled 50 patients who underwent the first radiofrequency ablation of persistent AF. Left atrium endocardial voltage maps were obtained using a 3D electroanatomical mapping system during AF. The voltage maps consisted of at least 2,000 points, with an average of 2,128±104 points. Low-voltage areas (LVA) were defined as <0.5 mV. The percentage of LVA% and very LVA% were calculated.
Results. We found a statistically significant correlation of LVA% with age (p<0.001, r=0.720), female sex (p=0.016), and the duration of arrhythmic history at the time of the start of persistence (p<0.001, r=0.503). Based on the data obtained, an original scale was developed to predict LVA%. The scale includes age, female sex, and the duration of arrhyth

1. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10): 659- 66. https://doi.org/10.1056/NEJM199809033391003.

2. Seitz J, Bars C, Théodore G, et al. AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach. J Am Coll Cardiol. 2017;69(3): 303-21. https://doi.org/10.1016/j.jacc.2016.10.065.

3. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19): 1812-22. https://doi.org/10.1056/NEJMoa1408288.

4. Marrouche NF, Naccarelli GV, Akoum Y, et al. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation: The DECAAF Study. JAMA. 2014;312(17): 1805-14. https://doi.org/10.1001/jama.2014.3.

5. Sramko M, Peichl P, Wichterle D, et al. Clinical value of assessment of left atrial late gadolinium enhancement in patients undergoing ablation of atrial fibrillation. Int J Cardiol. 2015;179: 351-7. https://doi.org/10.1016/j.ijcard.2014.11.072.

6. Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13): 1758-67. https://doi.org/10.1161/CIRCULATIONAHA.108.811877.

7. Yamaguchi T, Tsuchiya T, Nagamoto Y, et al. Longterm results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regard to substrates and pulmonary vein reconnections. Europace. 2014;16(5): 511-20. https://doi.org/10.1093/europace/eut265.

8. Sanders P, Morton JB, Kistler PM, et al. Electrophysiological and electroanatomic characterization of the atria in sinus node disease: Evidence of diffuse atrial remodeling. Circulation. 2004;109(11): 1514-22. https://doi.org/10.1161/01.CIR.0000121734.47409.AA.

9. Anter E, Tschabrunn CM, Josephson ME. High-resolution mapping of scar-related atrial arrhythmias using smaller electrodes with closer interelectrode spacing. Circ Arrhythm Electrophysiol. 2015;8(3): 537-45. https://doi.org/10.1161/CIRCEP.114.002737.

10. Saghy L, Callans DJ, Garcia F, et al. Is there a relationship between complex fractionated atrial electrograms recorded during atrial fibrillation and sinus rhythm fractionation? Heart Rhythm. 2012;9(2): 181-8. https://doi.org/10.1016/j.hrthm.2011.09.062.

11. Lin Y, Yang B, Garcia FC, et al. Comparison of left atrial electrophysiologic abnormalities during sinus rhythm in patients with different type of atrial fibrillation. J Interv Card Electrophysiol. 2014;39(1): 57-67. https://doi.org/10.1007/s10840-013-9838-y.

12. Kornej J, Schumacher K, Dinov B, et al. Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation. Sci Rep. 2018;8(1): 12686. https://doi.org/10.1038/s41598-018-31133-x.

13. Kosiuk J, Dinov B, Kornej J, et al. Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score. Heart Rhythm. 2015;12(9): 2207-12. https://doi.org/10.1016/j.hrthm.2015.07.003.

14. Andrés Lahuerta A, Roberto C, Saiz FJ, et al. Atrial low voltage areas: A comparison between atrial fibrillation and sinus rhythm. Cardiol J. 2022;29(2): 252-62. https://doi.org/10.5603/CJ.a2021.0125.

15. Chen J, Arentz T, Cochet H, et al. Extent and spatial distribution of left atrial arrhythmogenic sites, late gadolinium enhancement at magnetic resonance imaging, and low-voltage areas in patients with persistent atrial fibrillation: comparison of imaging vs. electrical parameters of fibrosis and arrhythmogenesis. Europace. 2019;21(10): 1484-93. https://doi.org/10.1093/europace/euz159.

16. Qureshi NA, Kim SJ, Cantwell CD, et al. Voltage during atrial fibrillation is superior to voltage during sinus rhythm in localizing areas of delayed enhancement on magnetic resonance imaging: An assessment of the posterior left atrium in patients with persistent atrial fibrillation. Heart Rhythm. 2019;16(9): 1357-67. https://doi.org/10.1016/j.hrthm.2019.05.032.

17. Kiedrowicz RM, Wielusinski M, Wojtarowicz A, et al. Predictors of the voltage derived left atrial fibrosis in patients with long-standing persistent atrial fibrillation. Cardiol J. 2022;29(4): 660-9. https://doi.org/10.5603/CJ.a2020.0069.

18. Kornej J, Büttner P, Sommer P, et al. Prediction of electro-anatomical substrate using APPLE score and biomarkers. Europace. 2019;21(1): 54-9. https://doi.org/10.1093/europace/euy120.

19. Seewöster T, Kosich F, Sommer P, et al. Prediction of low-voltage areas using modified APPLE score. Europace. 2021;23(4): 575-80. https://doi.org/10.1093/europace/euaa311.

20. D’Ambrosio G, Romano S, Alothman O, et al. Computed tomography-derived left atrial volume index, sex, and age to predict the presence and the extent of left atrial low-voltage zones in patients with atrial fibrillation: The ZAQ score. J Cardiovasc Electrophysiol. 2020;31(4): 895- 902. https://doi.org/10.1111/jce.14391.

21. Matsuda Y, Masuda M, Asai M, et al. A new clinical risk score for predicting the prevalence of low-voltage areas in patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2020;31(12): 3150-8. https://doi.org/10.1111/jce.14761.

22. Gasimova NZ, Shabanov VV, Safonov NV, et al. Multipolar mapping in the management of different arrhythmias. Journal of Arrhythmology. 2024;31(1): 110-122 https://doi.org/10.35336/VA-1297.

23. Rodríguez-Mañero M, Valderrábano M, Baluja A, et al. Validating Left Atrial Low Voltage Areas During Atrial Fibrillation and Atrial Flutter Using Multielectrode Automated Electroanatomic Mapping. JACC Clin Electrophysiol. 2018;4(12): 1541-52. https://doi.org/10.1016/j.jacep.2018.08.015.

24. Nairn D, Eichenlaub M, Lehrmann H, et al. Spatial correlation of left atrial low voltage substrate in sinus rhythm versus atrial fibrillation: The rhythm specificity of atrial low voltage substrate. J Cardiovasc Electrophysiol. 2023;34(8): 1613-21. https://doi.org/10.1111/jce.15984.

25. Anyukhovsky EP, Sosunov EA, Plotnikov A, et al. Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. Cardiovasc Res. 2002;54: 462-9. https://doi.org/10.1016/S0008-6363(02)00271-7.

26. Gramley F, Lorenzen J, Knackstedt C, et al. Age-related atrial fibrosis. Age. 2009;31: 27-38. https://doi.org/10.1007/s11357-008-9077-9.

27. Kainuma S, Masai T, Yoshitatsu M, et al. Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation. Eur J Cardiothorac Surg. 2011;40(1): 61-9. https://doi.org/10.1016/j.ejcts.2010.11.008.

28. Platonov PG, Mitrofanova LB, Orshanskaya V, et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58(21): 2225-32. https://doi.org/10.1016/j.jacc.2011.05.061.

29. Cochet H, Mouries A, Nivet H, et al. Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J Cardiovasc Electrophysiol. 2015;26: 484-92. https://doi.org/10.1111/jce.12651.

30. Lip GY, Laroche C, Boriani G, et al. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace. 2015;17: 24-31. https://doi.org/10.1093/europace/euu155.

31. Xiaocheng C, Qiongwen H, Lei G, et al. Sex-related differences in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2019;21(10): 1509-18. https://doi.org/10.1093/europace/euz179.

32. Wong GR, Nalliah CJ, Lee G, et al. Sex-related differences in atrial remodeling in patients with atrial fibrillation: relationship to ablation outcomes. Circ Arrhythm Electrophysiol. 2022;15(1). https://doi.org/10.1161/CIRCEP.121.009925.

33. Kerr CR, Humphries K. Gender-related differences in atrial fibrillation. J Am Coll Cardiol. 2005;46: 1307-8. https://doi.org/10.1016/j.jacc.2005.07.007.

34. Kuck KH, Brugada J, Schlüter M, et al. The FIRE AND ICE Trial: What We Know, What We Can Still Learn, and What We Need to Address in the Future. J Am Heart Assoc. 2018;7(24). https://doi.org/10.1161/JAHA.118.010777.

35. Tanaka N, Inoue K, Kobori A, et al. Sex differences in atrial fibrillation ablation outcomes: insights from a largescale multicentre registry. Europace. 2020;22(9): 1345-57. https://doi.org/10.1093/europace/euaa104.

36. Sugumar H, Nanayakkara S, Chieng D, et al. Arrhythmia recurrence is more common in females undergoing multiple catheter ablation procedures for persistent atrial fibrillation: Time to close the gender gap. Heart Rhythm. 2020;17(5 Pt A):692-98. https://doi.org/10.1016/j.hrthm.2019.12.013.

37. Akoum N, Mahnkopf C, Kholmovski EG, et al. Age and sex differences in atrial fibrosis among patients with atrial fibrillation. Europace. 2018;20(7): 1086-92. https://doi.org/10.1093/europace/eux260.

38. Huo Y, Gaspar T, Pohl M, et al. Prevalence and predictors of low voltage zones in the left atrium in patients with atrial fibrillation. Europace. 2018;20(6): 956-62. https://doi.org/10.1093/europace/eux082.

39. Wu N, Liu W, Yang G, et al. Sex difference in atrial scar prevalence: What can we learn from the STABLE-SRIII trial? Heart Rhythm. 2024;21(7): 1001-07. https://doi.org/10.1016/j.hrthm.2024.02.020.

40. Ammar-Busch S, Buiatti A, Tatzber A, et al. Predictors of low voltage areas in persistent atrial fibrillation: is it really a matter of time? J Interv Card Electrophysiol. 2020;57: 345-52. https://doi.org/10.1007/s10840-018-0471-7.

41. Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35): 2746-51. https://doi.org/10.1093/eurheartj/eht280.

42. Mahajan R, Lau DH, Brooks AG, et al. Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity. J Am Coll Cardiol. 2015;66: 1-11. https://doi.org/10.1016/j.jacc.2015.04.058.

43. Matsuda Y, Masuda M, Asai M, et al. Impact of Renal Dysfunction on Left Atrial Low-Voltage Areas in Patients With Atrial Fibrillation. Circ J. 2019;83(5): 985-90. https://doi.org/10.1253/circj.CJ-18-1277.

44. Seewöster T, Büttner P, Zeynalova S, et al. Are the atrial natriuretic peptides a missing link predicting low-voltage areas in atrial fibrillation? Introducing the novel biomarker-based atrial fibrillation substrate prediction (ANP) score. Clin Cardiol. 2020;43(7): 762-68. https://doi.org/10.1002/clc.23378.

45. Kiedrowicz RM, Wielusiński M, Wojtarowicz A, et al. Atrial fibrillation risk scores to evaluate left atrial substrate based on voltage analysis in long-standing persistent type of arrhythmia. Kardiol Pol. 2021;79(5): 525-30. https://doi.org/10.33963/kp.15902.